Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 253

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia: The COVID STEROID 2 Randomized Trial

Open access
The COVID STEROID 2 Trial Group, Russell, Lene, Uhre, Kis Rønn, Lindgaard, Ann Louise Syraach, Degn, Jette Fredlund, Wetterslev, Mik, Sivapalan, Praleene, Anthon, Carl Thomas, Mikkelsen, Vibe Sommer, la Porta, Louise Colette, Jensen, Thomas Steen, Levin, Charlotte Kastberg, Kronborg, Gitte, Krogh-Madsen, Rikke, Plovsing, Ronni Thermann Reitz, Brix, Helene, Schønemann-Lund, Martin, Valbjørn, Lone, Lauritzen, Sanne, Koch, Ellen Bjerre, Sørensen, Valdemar Oskar Ingemann, Seitz-Rasmussen, Hans Eric Sebastian, Bestle, Frederik Heiberg, Andersen-Ranberg, Nina Christine, Mortensen, Camilla Bekker, Derby, Cecilie Bauer, Stormholt, Emma Ritsmer, Cao, Yifei, Strøm, Thomas Steen, Lærkner, Eva, Gilberg, Christine, Poulsen, Michella, Olsen, Hanne Tanghus, Rosenkilde, Charlotte, Haberlandt, Trine, Andersen, Lars Peter Kloster, Jensen, Diana Bertelsen, Hansen, Mia Charlotte Krogh, Aagaard, Søren Rosborg, Vestergaard, Stine Rom, Bunzel, Anne-Marie Gellert, Siegumfeldt, Rine Moulvad, Klitgaard, Thomas Lass, Krejberg, Kirsten Uldal, Nielsen, Henrik, Elvira, Evangeline, Kumari, Hilda Nirmala, Swaminathan, Jayanthi, Chander, K Arun, Rajan, N Ganesh, Thomas, Sona, Thomas, Ann, Odankadummai, Vishnu, Antony, Anu M, Kulkarni, Atul P, Baliga, Nishanth, Lodh, Nirmalyo, Vijayakumaran, Swapna C, Kalvit, Kushal, Sahu, Tarun, Patil, Vijaya P, Kothekar, Amol T, Bhosale, Shilpushp J, Gorade, Manoj, Shrivastava, Anjana M, Uddhavrao, Jare Jagannath, Sharma, Ritika, Mali, Jyotsna, Niranjan, H R, Lobo, Celine, Neve, Vaishali, Maurya, Deepika, Salunke, Mahesh, Pattanaik, Santiswaroop, Agrawal, Akhliesh, Hegde, Ashit, Badgurjar, Rishi Kumar, Jhaveri, Binit N, Sarje, Digamber B, Ananda, H.J, Sen, Bitan, Ambily, C.M, Jose, Emilin P, Kadam, Vaijayanti, Chiluka, Annapurna, Kuril, Rohit, Mathew, Elizabeth, Shirsekar, Survana, Kansal, Sudha, Dahiya, Rinku, Thakur, Vijaya Kumar, Tewatia, Rajni, Rawat, Savita, Tyagi, Harsh, Bhakare, Meenakshi, Bhise, Chinmayee, Girme, Amit, Kunjumon, Lini T, Jose, Merlin, Sharma, Nikunj, Bali, Amol, Patel, Mayr, Bhutaka, Nirankar, Pathrose, Edwin, Goyal, Gopal, Baby, Riya, Fernandez, Roshini, Bhattacharya, Pradip K, Kindo, Srishti, Aaditya, A., Raj, Kritiaka, Poddar, Aastha, Ansari, Aftab, Alam, Mustaque, Khandagale, Vijay, Sarode, Satish, Garde, Sanesh, Shinde, Sushant, Jagtap, Narndev, Khartode, Chagan, Palange, Amit, Pawar, Aishwarya, Mulay, Mayuri, Pirzade, Simrah, Jagtap, Mohini, Rathod, Balbhim, Tanna, Dhara, Chaudhary, Kinjal, Deshpande, Shubhangi, Raj, Rikin, Ambapkar, Sourab, Ambapkar, Shobhana, Penurkar, Mukund, Sambare, Amit, Joshi, Ravindra, Kinolkar, Bhushan, Shaikh, Tarannum Aslam, Didriksson, Helen, Jönsson, Carina, Gagnö, Gunilla, Zacharias, David, Jong, Margaret Lynn, Roth, Marianne, Mader, Rachelle, Fazlija, Laureta, Akaltan, Manuela, Eichenberger, Anjana, Rüegg, Gion, Dill, Tatjana, Schoenmaekers, Bruno, Kumar, Ashwani, Rajbhandari, Dorrilyn, Arfin, Sumaiya, Bathla, Nikita, Joshi, Rajesh, Kunigari, Mallikarjuna, Munch, Marie W., Myatra, Sheila N., Vijayaraghavan, Bharath Kumar Tirupakuzhi, Saseedharan, Sanjith, Benfield, Thomas, Wahlin, Rebecka R., Rasmussen, Bodil S., Andreasen, Anne Sofie, Poulsen, Lone M., Cioccari, Luca, Khan, Mohd S., Kapadia, Farhad, Divatia, Jigeeshu V., Brøchner, Anne C., Bestle, Morten H., Helleberg, Marie, Michelsen, Jens, Padmanaban, Ajay, Bose, Neeta, Møller, Anders, Borawake, Kapil, Kristiansen, Klaus T., Shukla, Urvi, Chew, Michelle S., Dixit, Subhal, Ulrik, Charlotte S., Amin, Pravin R., Chawla, Rajesh, Wamberg, Christian A., Shah, Mehul S., Darfelt, Iben S., Jørgensen, Vibeke L., Smitt, Margit, Granholm, Anders, Kjær, Maj-Brit N., Møller, Morten H., Meyhoff, Tine S., Vesterlund, Gitte K., Hammond, Naomi E., Micallef, Sharon, Bassi, Abhinav, John, Oommen, Jha, Anubhuti, Cronhjort, Maria, Jakob, Stephan M., Gluud, Christian, Lange, Theis, Kadam, Vaijayanti, Marcussen, Klaus V., Hollenberg, Jacob, Hedman, Anders, Nielsen, Henrik, Schjørring, Olav L., Jensen, Marie Q., Leistner, Jens W., Jonassen, Trine B., Kristensen, Camilla M., Clapp, Esben C., Hjortsø, Carl J. S., Jensen, Thomas S., Halstad, Liv S., Bak, Emilie R. B., Zaabalawi, Reem, Metcalf-Clausen, Matias, Abdi, Suhayb, Hatley, Emma V., Aksnes, Tobias S., Gleipner-Andersen, Emil, Alarcón, Arif F., Yamin, Gabriel, Heymowski, Adam, Berggren, Anton, La Cour, Kirstine, Weihe, Sarah, Pind, Alison H., Engstrøm, Janus, Jha, Vivekanand, Venkatesh, Balasubramanian, Perner, Anders·2021·JAMA

Abstract

Importance: A daily dose with 6 mg of dexamethasone is recommended for up to 10 days in patients with severe and critical COVID-19, but a higher dose may benefit those with more severe disease. Objective: To assess the effects of 12 mg/d vs 6 mg/d of dexamethasone in patients with COVID-19 and severe hypoxemia. Design, Setting, and Participants: A multicenter, randomized clinical trial was conducted between August 2020 and May 2021 at 26 hospitals in Europe and India and included 1000 adults with confirmed COVID-19 requiring at least 10 L/min of oxygen or mechanical ventilation. End of 90-day follow-up was on August 19, 2021. Interventions: Patients were randomized 1:1 to 12 mg/d of intravenous dexamethasone (n = 503) or 6 mg/d of intravenous dexamethasone (n = 497) for up to 10 days. Main Outcomes and Measures: The primary outcome was the number of days alive without life support (invasive mechanical ventilation, circulatory support, or kidney replacement therapy) at 28 days and was adjusted for stratification variables. Of the 8 prespecified secondary outcomes, 5 are included in this analysis (the number of days alive without life support at 90 days, the number of days alive out of the hospital at 90 days, mortality at 28 days and at 90 days, and ≥1 serious adverse reactions at 28 days). Results: Of the 1000 randomized patients, 982 were included (median age, 65 [IQR, 55-73] years; 305 [31%] women) and primary outcome data were available for 971 (491 in the 12 mg of dexamethasone group and 480 in the 6 mg of dexamethasone group). The median number of days alive without life support was 22.0 days (IQR, 6.0-28.0 days) in the 12 mg of dexamethasone group and 20.5 days (IQR, 4.0-28.0 days) in the 6 mg of dexamethasone group (adjusted mean difference, 1.3 days [95% CI, 0-2.6 days]; P = .07). Mortality at 28 days was 27.1% in the 12 mg of dexamethasone group vs 32.3% in the 6 mg of dexamethasone group (adjusted relative risk, 0.86 [99% CI, 0.68-1.08]). Mortality at 90 days was 32.0% in the 12 mg of dexamethasone group vs 37.7% in the 6 mg of dexamethasone group (adjusted relative risk, 0.87 [99% CI, 0.70-1.07]). Serious adverse reactions, including septic shock and invasive fungal infections, occurred in 11.3% in the 12 mg of dexamethasone group vs 13.4% in the 6 mg of dexamethasone group (adjusted relative risk, 0.83 [99% CI, 0.54-1.29]). Conclusions and Relevance: Among patients with COVID-19 and severe hypoxemia, 12 mg/d of dexamethasone compared with 6 mg/d of dexamethasone did not result in statistically significantly more days alive without life support at 28 days. However, the trial may have been underpowered to identify a significant difference. Trial Registration: ClinicalTrials.gov Identifier: NCT04509973 and ctri.nic.in Identifier: CTRI/2020/10/028731.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jama.2021.18295

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 21 references

Cited by

See all 253

Metadata

Authors
The COVID STEROID 2 Trial Group, Russell, L., Uhre, K. R., Lindgaard, A. L. S., Degn, J. F., Wetterslev, M., Sivapalan, P., Anthon, C. T., Mikkelsen, V. S., la Porta, L. C., Jensen, T. S., Levin, C. K., Kronborg, G., Krogh-Madsen, R., Plovsing, R. T. R., Brix, H., Schønemann-Lund, M., Valbjørn, L., Lauritzen, S., Koch, E. B., Sørensen, V. O. I., Seitz-Rasmussen, H. E. S., Bestle, F. H., Andersen-Ranberg, N. C., Mortensen, C. B., Derby, C. B., Stormholt, E. R., Cao, Y., Strøm, T. S., Lærkner, E., Gilberg, C., Poulsen, M., Olsen, H. T., Rosenkilde, C., Haberlandt, T., Andersen, L. P. K., Jensen, D. B., Hansen, M. C. K., Aagaard, S. R., Vestergaard, S. R., Bunzel, A.-M. G., Siegumfeldt, R. M., Klitgaard, T. L., Krejberg, K. U., Nielsen, H., Elvira, E., Kumari, H. N., Swaminathan, J., Chander, K. A., Rajan, N. G., Thomas, S., Thomas, A., Odankadummai, V., Antony, A. M., Kulkarni, A. P., Baliga, N., Lodh, N., Vijayakumaran, S. C., Kalvit, K., Sahu, T., Patil, V. P., Kothekar, A. T., Bhosale, S. J., Gorade, M., Shrivastava, A. M., Uddhavrao, J. J., Sharma, R., Mali, J., Niranjan, H. R., Lobo, C., Neve, V., Maurya, D., Salunke, M., Pattanaik, S., Agrawal, A., Hegde, A., Badgurjar, R. K., Jhaveri, B. N., Sarje, D. B., Ananda, H. J., Sen, B., Ambily, C. M., Jose, E. P., Kadam, V., Chiluka, A., Kuril, R., Mathew, E., Shirsekar, S., Kansal, S., Dahiya, R., Thakur, V. K., Tewatia, R., Rawat, S., Tyagi, H., Bhakare, M., Bhise, C., Girme, A., Kunjumon, L. T., Jose, M., Sharma, N., Bali, A., Patel, M., Bhutaka, N., Pathrose, E., Goyal, G., Baby, R., Fernandez, R., Bhattacharya, P. K., Kindo, S., Aaditya, A., Raj, K., Poddar, A., Ansari, A., Alam, M., Khandagale, V., Sarode, S., Garde, S., Shinde, S., Jagtap, N., Khartode, C., Palange, A., Pawar, A., Mulay, M., Pirzade, S., Jagtap, M., Rathod, B., Tanna, D., Chaudhary, K., Deshpande, S., Raj, R., Ambapkar, S., Ambapkar, S., Penurkar, M., Sambare, A., Joshi, R., Kinolkar, B., Shaikh, T. A., Didriksson, H., Jönsson, C., Gagnö, G., Zacharias, D., Jong, M. L., Roth, M., Mader, R., Fazlija, L., Akaltan, M., Eichenberger, A., Rüegg, G., Dill, T., Schoenmaekers, B., Kumar, A., Rajbhandari, D., Arfin, S., Bathla, N., Joshi, R., Kunigari, M., Munch, M. W., Myatra, S. N., Vijayaraghavan, B. K. T., Saseedharan, S., Benfield, T., Wahlin, R. R., Rasmussen, B. S., Andreasen, A. S., Poulsen, L. M., Cioccari, L., Khan, M. S., Kapadia, F., Divatia, J. V., Brøchner, A. C., Bestle, M. H., Helleberg, M., Michelsen, J., Padmanaban, A., Bose, N., Møller, A., Borawake, K., Kristiansen, K. T., Shukla, U., Chew, M. S., Dixit, S., Ulrik, C. S., Amin, P. R., Chawla, R., Wamberg, C. A., Shah, M. S., Darfelt, I. S., Jørgensen, V. L., Smitt, M., Granholm, A., Kjær, M.-B. N., Møller, M. H., Meyhoff, T. S., Vesterlund, G. K., Hammond, N. E., Micallef, S., Bassi, A., John, O., Jha, A., Cronhjort, M., Jakob, S. M., Gluud, C., Lange, T., Kadam, V., Marcussen, K. V., Hollenberg, J., Hedman, A., Nielsen, H., Schjørring, O. L., Jensen, M. Q., Leistner, J. W., Jonassen, T. B., Kristensen, C. M., Clapp, E. C., Hjortsø, C. J. S., Jensen, T. S., Halstad, L. S., Bak, E. R. B., Zaabalawi, R., Metcalf-Clausen, M., Abdi, S., Hatley, E. V., Aksnes, T. S., Gleipner-Andersen, E., Alarcón, A. F., Yamin, G., Heymowski, A., Berggren, A., La Cour, K., Weihe, S., Pind, A. H., Engstrøm, J., Jha, V., Venkatesh, B., & Perner, A.
Venue
JAMA
Published
2021-11-09
Volume
326
Issue
18
Pages
1807
ISSN
  • 0002-9955 (ISSN-L)
  • 0098-7484
OpenAlex
W3206865065
Cited by
253
References
21
FWCI
16.95
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia: The COVID STEROID 2 Randomized Trial. https://app.cochat.ai/papers/10.1001/jama.2021.18295
The paper
The COVID STEROID 2 Trial Group, Russell, L., Uhre, K. R., Lindgaard, A. L. S., Degn, J. F., Wetterslev, M., Sivapalan, P., Anthon, C. T., Mikkelsen, V. S., la Porta, L. C., Jensen, T. S., Levin, C. K., Kronborg, G., Krogh-Madsen, R., Plovsing, R. T. R., Brix, H., Schønemann-Lund, M., Valbjørn, L., Lauritzen, S., . . . Perner, A. (2021). Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia: The COVID STEROID 2 Randomized Trial. JAMA. https://doi.org/10.1001/jama.2021.18295

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.